Ginkgo Bioworks Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DNA research report →
Companywww.ginkgobioworks.com
Ginkgo Bioworks Holdings, Inc. , together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.
- CEO
- Jason Kelly
- IPO
- 2021
- Employees
- 834
- HQ
- Boston, MA, US
Price Chart
Valuation
- Market Cap
- $504.31M
- P/E
- -1.51
- P/S
- 3.57
- P/B
- 1.04
- EV/EBITDA
- -3.74
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 74.97%
- Op Margin
- -210.66%
- Net Margin
- -215.41%
- ROE
- -57.31%
- ROIC
- -31.12%
Growth & Income
- Revenue
- $170.16M · -25.06%
- Net Income
- $-312,763,000 · 42.83%
- EPS
- $-5.64 · 46.49%
- Op Income
- $-315,278,000
- FCF YoY
- 53.23%
Performance & Tape
- 52W High
- $17.58
- 52W Low
- $5.37
- 50D MA
- $7.54
- 200D MA
- $9.81
- Beta
- 1.78
- Avg Volume
- 1.43M
Get TickerSpark's AI analysis on DNA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 16, 26 | Coen Steven P. | other | 156 |
| Apr 16, 26 | Coen Steven P. | other | 587 |
| Apr 17, 26 | Coen Steven P. | sell | 324 |
| Apr 16, 26 | Coen Steven P. | other | 587 |
| Apr 16, 26 | Coen Steven P. | other | 156 |
| Apr 10, 26 | Coen Steven P. | other | 45,553 |
| Apr 13, 26 | Coen Steven P. | sell | 33,171 |
| Apr 10, 26 | Coen Steven P. | other | 28,368 |
| Apr 10, 26 | Coen Steven P. | other | 45,553 |
| Apr 9, 26 | Canton Barry | other | 251,786 |
Our DNA Coverage
We haven't published any research on DNA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate DNA Report →